Famiclov Tablet
Famciclovir
Aadee Remedies Pvt. Ltd
Pack size | |
---|---|
Dispensing mode | |
Source | |
Agent | |
Retail Price |
Indications
Famiclov Tablet is used for:
Genital herpes, Herpes zoster, Herpes labialis, CMV infections, Mucocutaneous herpes
Adult Dose
Acute Herpes Zoster (Shingles)
Treatment in immunocompetent adults
500 mg PO q8hr for 7 days; initiated within 72 hours of symptom or lesion onset
Herpes Labialis
Treatment of initial and recurrent episodes or suppressive therapy in immunocompetent adults
Initial episode: 250 mg PO q8hr for 7-10 days
Suppressive therapy: 250 mg PO q12hr for 12 months
Recurrent episodes: 1500 mg PO once; initiate therapy at first sign (within 1 hour) of symptoms such as tingling, itching or burning
Genital Herpes
Treatment of initial and recurrent episodes or suppressive therapy in immunocompetent adults
Initial episode: 250 mg PO q8hr for 7-10 days
Suppressive therapy: 250 mg PO q12hr for up to 12 months
Recurrent episodes: 1000 mg PO q12hr for 1 day; initiated within 6 hours of symptom or lesion onset
Herpes (HIV-Infected Adults)
Prevention of herpes simplex virus (HSV) reactivation and treatment of recurrent episodes
Prevention of HSV reactivation: 500 mg PO q12hr
Recurrent episodes: 500 mg PO q12hr for 5-10 days; initiated within 48 hours of symptom or lesion onset
Child Dose
Renal Dose
Acute herpes zoster
CrCl >60 mL/min: Regular dosage
CrCl 40-59 mL/min: 500 mg q12hr
CrCl 20-39 mL/min: 500 mg once daily
CrCl <20 mL/min: 250 mg once daily
Hemodialysis: 250 mg after each session
Herpes labialis
CrCl >60 mL/min: Regular dosage
CrCl 40-59 mL/min: 750 mg once
CrCl 20-39 mL/min: 500 mg once
CrCl <20 mL/min: 250 mg once
Hemodialysis: 250 mg once after dialysis
Genital herpes (treatment of recurrent disease)
CrCl >60 mL/min: Regular dosage
CrCl 40-59 mL/min: 500 mg q12hr for 1 day (2 doses total)
CrCl 20-39 mL/min: 500 mg once
CrCl <20 mL/min: 250 mg once
Hemodialysis: 250 mg once after dialysis
Genital herpes (suppressive therapy)
CrCl >40 mL/min: Regular dosage
CrCl 20-39 mL/min: 125 mg q12hr
CrCl <20 mL/min: 125 mg/day
Hemodialysis: 125 mg after each session
Herpes (HIV-infected adults)
CrCl >40 mL/min: Regular dosage
CrCl 20-39 mL/min: 500 mg/day
CrCl <20 mL/min: 250 mg/day
Hemodialysis: 250 mg after each session
Administration
May be taken with or without food.
Contra Indications
Hypersensitivity. Lactation.
Precautions
Renal impairment. Pregnancy.
Lactation: Unknown whether drug is excreted in breast milk; caution advised
Pregnancy-Lactation
Interactions
Reduced renal excretion resulting to increased plasma concentration w/ probenecid. Raloxifen may reduce the formation of penciclovir, the active metabolite of famciclovir.
Adverse Effects
Side effects of Famciclovir :
>10%
Headache (23%),Nausea (13%)
1-10%
Diarrhea (2-9%),Abdominal pain (8%),Dysmenorrhea (<8%),Vomiting (1-5%),Flatulence (5%),Pruritus (4%),Rash (3%),Paresthesia (3%),Neutropenia (3%),Increased transaminases (2-3%),Increased bilirubin (2%),Fatigue (1%)
<1%
Arthralgia,Confusion,Dizziness,Erythema multiforme,Hallucinations,Jaundice,Rigors,Thrombocytopenia,Upper respiratory tract infection
Mechanism of Action
Famciclovir rapidly undergoes biotransformation to penciclovir, which has inhibitory activity against HSV types 1 (HSV-1) and 2 (HSV-2) varicella-zoster virus (VZV). Thymidine kinase then phosphorylates penciclovir to a monophosphate form, which is then converted to penciclovir triphosphate. This inhibits HSV-2 DNA polymerase by competing with deoxyguanosine triphosphate, thus inhibiting herpes viral DNA synthesis and replication.
Note
Famiclov Tablet manufactured by Aadee Remedies Pvt. Ltd. Its generic name is Famciclovir. Famiclov is availble in Nepal.
Farmaco Nepal drug index information on Famiclov Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.